Table 2.
Clinical characteristics table
| Variablea | Total N = 26 |
|---|---|
| Time since diagnosis (in months) | |
| Total population: Mean (SD) | 17.20 (12.7) |
| Total population: Median | 13.00 |
| Limited: Mean (SD) | 18.00 (12.7) |
| Limited: Median | 12.00 |
| Limited: Interquartile range | 11.00 |
| Extensive: Mean (SD) | 19.00 (15.4) |
| Extensive: Median | 14.00 |
| Extensive: Interquartile range | 7.00 |
| Stage of SCLC—n(%) | |
| Limited | 11 (42.3%) |
| Extensive | 9 (34.6%) |
| Missing | 6 (23.1%) |
| Has been told by doctor they are platinum-resistant or sensitive—n(%) | 11 (42.3%) |
| Treatments received | |
| Surgery | 3 (11.5%) |
| Radiation | 10 (38.5%) |
| Immunotherapy | 2 (7.7%) |
| Chemotherapy | 23 (88.5%) |
| Other | 4 (15.4%) |
aMissing data included in calculation of percentages